Question to the Department of Health and Social Care:

To ask His Majesty's Government what steps they are taking to protect NHS services and patients from the development of drug-resistant pathogens.

Pathogens develop resistance to antimicrobial treatments, such as antibiotics, through inappropriate use and unintentional exposure through the environment and our food. This is driving rates of antimicrobial resistance (AMR) and is creating a generation of ‘superbugs’ that cannot be treated with existing medicines and treatments, leading to longer hospital stays and more complex treatment pathways.

The Government’s UK 5-year action plan for antimicrobial resistance 2024 to 2029, a copy of which is attached, is committed to reducing the rate of drug-resistant infections and AMR through a series of commitments that aim to reduce the need for, and unintentional exposure to, antimicrobials. This aims to preserve the effectiveness of antimicrobials. The national action plan also commits to meeting specific targets to reduce drug-resistant infections by 2029, including preventing their increase in humans and any increase in gram-negative bloodstream infections from the specified 2019/20 financial year baseline.

NHS England implements its responsibilities under the national action plan through a set of workstreams, each with responsibility for a set of these commitments. The central AMR programme team within NHS England works with partners within the UK Health Security Agency and the Department to co-ordinate and ensure delivery. Regional NHS England leads work with integrated care boards to advise on, and support actions locally, to reduce infection and the need for antimicrobials.